JPET

Home Help [Feedback] [For Subscribers] [Archive] [Search] [Contents]
 QUICK SEARCH:   [advanced]


     


Journal of Pharmacology And Experimental Therapeutics Fast Forward
First published on September 9, 2003; DOI: 10.1124/jpet.103.052100


0022-3565/03/3072-437-442$20.00
JPET 307:437-442, 2003
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
jpet.103.052100v1
307/2/437    most recent
Right arrow Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Trejo, J.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Trejo, J.

PERSPECTIVES IN PHARMACOLOGY

Protease-Activated Receptors: New Concepts in Regulation of G Protein-Coupled Receptor Signaling and Trafficking

Joann Trejo

Department of Pharmacology, Cardiovascular Biology Center, Lineberger Comprehensive Cancer Center, School of Medicine, University of North Carolina at Chapel Hill, Chapel Hill, North Carolina

Most G protein-coupled receptors (GPCRs) are reversibly activated upon ligand binding. However, activation of protease-activated G protein-coupled receptors (PARs) occurs through an irreversible proteolytic event that results in the generation of a tethered ligand that cannot diffuse away. This unusual mode of PAR activation raises important questions regarding the mechanisms responsible for termination of receptor signaling. There are currently four members of the PAR family. Thrombin activates PAR1, PAR3, and PAR4, whereas multiple trypsin-like serine proteases activate PAR2. The regulation of signaling by PAR1 has been extensively studied, whereas considerably less is known about the other PARs. It has been demonstrated that rapid termination of PAR1 signaling is critical in determining the magnitude and kinetics of the cellular protease response. Therefore, elucidating the molecular mechanisms involved in the regulation of PAR signaling is essential to fully understand protease-mediated responses. Recent findings indicate that novel mechanisms contribute to PAR1 desensitization, internalization, and down-regulation. This review focuses on the intracellular mechanisms that regulate PAR signaling and the recent progress in developing inhibitors of PAR signaling.


Received for publication May 7, 2003
Accepted July 2, 2003.

Address correspondence to: JoAnn Trejo, Ph.D., University of North Carolina at Chapel Hill, Department of Pharmacology, 1106 Mary Ellen Jones Bldg., CB #7365, Chapel Hill, NC 27599-7365. E-mail: joann_trejo{at}med.unc.edu




This article has been cited by other articles:


Home page
J. Biol. Chem.Home page
L. Seminario-Vidal, S. Kreda, L. Jones, W. O'Neal, J. Trejo, R. C. Boucher, and E. R. Lazarowski
Thrombin Promotes Release of ATP from Lung Epithelial Cells through Coordinated Activation of Rho- and Ca2+-dependent Signaling Pathways
J. Biol. Chem., July 31, 2009; 284(31): 20638 - 20648.
[Abstract] [Full Text] [PDF]


Home page
StrokeHome page
Y. Kai, K. Hirano, Y. Maeda, J. Nishimura, T. Sasaki, and H. Kanaide
Prevention of the Hypercontractile Response to Thrombin by Proteinase-Activated Receptor-1 Antagonist in Subarachnoid Hemorrhage
Stroke, December 1, 2007; 38(12): 3259 - 3265.
[Abstract] [Full Text] [PDF]


Home page
Ann OncolHome page
I Jahan, J Fujimoto, S. M. Alam, E Sato, H Sakaguchi, and T Tamaya
Role of protease activated receptor-2 in tumor advancement of ovarian cancers
Ann. Onc., September 1, 2007; 18(9): 1506 - 1512.
[Abstract] [Full Text] [PDF]


Home page
BloodHome page
S. K. Mandal, U. R. Pendurthi, and L. V. M. Rao
Tissue factor trafficking in fibroblasts: involvement of protease-activated receptor-mediated cell signaling
Blood, July 1, 2007; 110(1): 161 - 170.
[Abstract] [Full Text] [PDF]


Home page
J. Pharmacol. Exp. Ther.Home page
K. A. Berg, A. M. Patwardhan, T. A. Sanchez, Y. M. Silva, K. M. Hargreaves, and W. P. Clarke
Rapid Modulation of {micro}-Opioid Receptor Signaling in Primary Sensory Neurons
J. Pharmacol. Exp. Ther., June 1, 2007; 321(3): 839 - 847.
[Abstract] [Full Text] [PDF]


Home page
Mol. Pharmacol.Home page
M. A. Ayoub, D. Maurel, V. Binet, M. Fink, L. Prezeau, H. Ansanay, and J.-P. Pin
Real-Time Analysis of Agonist-Induced Activation of Protease-Activated Receptor 1/G{alpha}i1 Protein Complex Measured by Bioluminescence Resonance Energy Transfer in Living Cells
Mol. Pharmacol., May 1, 2007; 71(5): 1329 - 1340.
[Abstract] [Full Text] [PDF]


Home page
Mol. Pharmacol.Home page
M. D. Hains, M. R. Wing, S. Maddileti, D. P. Siderovski, and T. K. Harden
G{alpha}12/13- and Rho-Dependent Activation of Phospholipase C-{epsilon} by Lysophosphatidic Acid and Thrombin Receptors
Mol. Pharmacol., June 1, 2006; 69(6): 2068 - 2075.
[Abstract] [Full Text] [PDF]


Home page
J. Pharmacol. Exp. Ther.Home page
T. A. Cheema, C. E. Ward, and S. K. Fisher
Subnanomolar Concentrations of Thrombin Enhance the Volume-Sensitive Efflux of Taurine from Human 1321N1 Astrocytoma Cells
J. Pharmacol. Exp. Ther., November 1, 2005; 315(2): 755 - 763.
[Abstract] [Full Text] [PDF]


Home page
Arterioscler. Thromb. Vasc. Bio.Home page
T. Yufu, K. Hirano, D. Bi, M. Hirano, J. Nishimura, Y. Iwamoto, and H. Kanaide
Rac1 Regulation of Surface Expression of Protease-Activated Receptor-1 and Responsiveness to Thrombin in Vascular Smooth Muscle Cells
Arterioscler Thromb Vasc Biol, July 1, 2005; 25(7): 1506 - 1511.
[Abstract] [Full Text] [PDF]


Home page
Mol. Pharmacol.Home page
L. Stalheim, Y. Ding, A. Gullapalli, M. M. Paing, B. L. Wolfe, D. R. Morris, and J. Trejo
Multiple Independent Functions of Arrestins in the Regulation of Protease-Activated Receptor-2 Signaling and Trafficking
Mol. Pharmacol., January 1, 2005; 67(1): 78 - 87.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
A. Heydorn, B. P. Sondergaard, B. Ersboll, B. Holst, F. C. Nielsen, C. R. Haft, J. Whistler, and T. W. Schwartz
A Library of 7TM Receptor C-terminal Tails: INTERACTIONS WITH THE PROPOSED POST-ENDOCYTIC SORTING PROTEINS ERM-BINDING PHOSPHOPROTEIN 50 (EBP50), N-ETHYLMALEIMIDE-SENSITIVE FACTOR (NSF), SORTING NEXIN 1 (SNX1), AND G PROTEIN-COUPLED RECEPTOR-ASSOCIATED SORTING PROTEIN (GASP)
J. Biol. Chem., December 24, 2004; 279(52): 54291 - 54303.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
C. Debaigt, H. Hirling, P. Steiner, J.-P. Vincent, and J. Mazella
Crucial Role of Neuron-enriched Endosomal Protein of 21 kDa in Sorting between Degradation and Recycling of Internalized G-protein-coupled Receptors
J. Biol. Chem., August 20, 2004; 279(34): 35687 - 35691.
[Abstract] [Full Text] [PDF]




Home Help [Feedback] [For Subscribers] [Archive] [Search] [Contents]
All ASPET Journals Molecular Pharmacology Pharmacological Reviews
 Molecular Interventions Drug Metabolism and Disposition

Copyright © 2003 by the American Society for Pharmacology and Experimental Therapeutics.